CClinicalTrials.gg
CompletedNCT06911398Updated Apr 20, 2026

AMIE's Clinical Conversational Abilities in an Urgent Care Setting

An observational study in Artificial Intelligence (AI) and Clinical Reasoning, sponsored by Beth Israel Deaconess Medical Center. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-04-20.

Sponsored by Beth Israel Deaconess Medical Center · Observational

Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
100
Ages
18 Years and older
Sex
All
01

Study summary

The purpose of this study is to determine the feasibility of a conversational artificial intelligence (AI) system to have a meaningful clinical conversation with a patient prior to an urgent care visit with their primary care physician. In this study, patients who are seeking an urgent care visit (that is, any type of medical visit with their primary care provider for a new complaint) will first have a conversation with an AI system. This interaction with the AI system will happen less than a week before their visit with their physician, and will be supervised by an independent physician who will interrupt in case there are any concerns about patient safety. After the interaction, a summary of the conversation will be sent to the patient's PCP, who will review prior to the in-person visit.

The researchers will investigate:

  • Patient views on the AI system
  • PCP views on the AI system
  • Overall safety, as measured by the physician safety supervisor
  • Quality of clinical conversations, measured by standardized rubrics
  • Quality of diagnostic and management plans generated by the AI; these will not be shared with the patient or physician, but will be generated after the fact and compared with the actual diagnosis and management plan.
Read the detailed description

This study is a pilot study on the ability of the Articulate Medical Intelligence Explorer's ability to have a clinical conversation with urgent care patients. After recruitment into the study, but prior to seeing their primary care physician (PCP), patients will log in to the AMIE chat interface via a secure web application and share their screen via a secure, HIPAA-compliant video conferencing program. They will then interact with AMIE, having a clinical conversation. A physician safety supervisor will be on the call the entire time and will view the chat as it happens. This doctor will interrupt the chat if there are any potentially harmful interactions. At the end of the call, the safety supervisor will discuss with the patient and correct any errors, hallucinations, or problems with the AI. The patient's PCP will receive both a summary and a transcript of the chat prior to their appointment. The patient will then proceed to their urgent care appointment as previously scheduled. Four weeks after the visit, the researchers will perform a chart review to extract a "ground truth" diagnosis from the urgent care visit, if possible. As this is a pilot study, the primary endpoint will be recruitment; the target is between 100 to 200 patients and the study will continue until saturation of different diagnoses has been reached.

02

Conditions studied

  • Artificial Intelligence (AI)
  • Clinical Reasoning

Keywords

  • artificial intelligence
  • chatbot
  • clinical conversation
03

In context

Lead sponsor

Beth Israel Deaconess Medical Center is the lead sponsor of 560 studies on the registry; 80 are open to participants now.

Of its 75 completed or terminated interventional studies of FDA-regulated products, 61 (81%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes
Sampling method
Non-probability sample

Study population

The study population is all patients meeting the inclusion and exclusion criteria undergoing an episodic care visit at Healthcare Associates (HCA), the primary care clinic of BIDMC.

Inclusion criteria

  • Age > 18
  • English included as a primary language in the electronic health record
  • Patient is seeking episodic (urgent) care at HCA

Exclusion criteria

Exclusion Criteria:

  • Age \< 18
  • English not listed as a primary language in the electronic health record
  • Visit reason is related to pregnancy
  • Visit reason is a psychiatric concern
  • Visit is to establish care, or for follow-up care
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
100 participants (actual)
Patient registry
No

Groups and cohorts

  • Urgent care patients

    Other: Articulate Medical Intelligence Explorer (AMIE)

Interventions

  • OtherArticulate Medical Intelligence Explorer (AMIE)

    AMIE is an AI system for having clinical conversations with patients

06

What researchers measure

Primary outcomes

  1. Chat terminations

    The researchers will collect the number of interruptions by the safety supervisor in response to safety concerns. There are four pre-specified interruption criteria; the researchers will connect the total number in each category, as well as a qualitative description of the type of error.

    Time frame: Day 1

  2. Patient-centered evaluation of clinical dialogue

    The researchers will use the General Medical Council Patient Questionnaire (GMCPQ) standardized rubric to rate the quality of clinical dialogue.

    Time frame: Day 3

  3. Clinical skills-based assessment of clinical dialogue

    The researchers will use the Practical Assessment of Clinical Examination Skills (PACES) standardized rubric to rate the quality of clinical dialogue.

    Time frame: Day 3

  4. Communication skills evaluation of clinical dialogue

    The researchers will use the Patient-Centered Communication Best Practice (PCCBP) standardized rubric to rate the quality of clinical dialogue.

    Time frame: Day 3

  5. Patient satisfaction pre-AMIE encounter

    Patients will receive a pre-AMIE encounter questionnaire.

    Time frame: Day 1

  6. Patient satisfaction post-AMIE encounter

    Patients will receive a post-AMIE encounter questionnaire.

    Time frame: Day 1

  7. PCP satisfaction

    The researchers will collect a post-encounter questionnaire from the patient's PCP, asking about views on AI in healthcare and how AMIE interaction may have changed the in-person visit.

    Time frame: Day 3

  8. Patient satisfaction post-PCP encounter

    Patients will receive a post-PCP encounter questionnaire.

    Time frame: Day 3

Secondary outcomes

  1. Semi-structured interviews of patients

    The researchers will perform semi-structured interviews of select patients participating in the study.

    Time frame: Up to 8 weeks

  2. Diagnostic accuracy

    The researchers will compare AMIE's differential diagnosis to the final diagnosis.

    Time frame: Up to 4 weeks

  3. Management plan quality

    The researchers will compare AMIE's management plan to the final management plan using the Management Reasoning Essential Key Features (MXEKF) rubric.

    Time frame: Up to 4 weeks

  4. Semi-structured interviews of PCPs

    The researchers will complete semi-structured interviews with all of the PCPs participating in the study.

    Time frame: Up to 8 weeks

07

Study locations

1 site
  • Beth Israel Deaconess Medical Center
    Boston, Massachusetts 02215, United States
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 20, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06911398
Lead sponsor
Beth Israel Deaconess Medical Center
Collaborators
Google LLC.
Responsible party
Marc Cohen (Assistant Professor of Medicine, Beth Israel Deaconess Medical Center) — Principal investigator
First posted
Apr 4, 2025
Start date
Apr 2, 2025
Primary completion
Jan 5, 2026
Completion
Apr 6, 2026
Last update
Apr 20, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion